Indonesia Will Make mRNA Covid Shots as Southeast Asia’s Vaccine Hub
- State-owned Bio Farma picked to start developing mRNA vaccines
- WHO sets up tech transfer hubs across developing countries
This article is for subscribers only.
Indonesia could start making its own mRNA vaccines after the World Health Organization picked it to receive a technology transfer to become Southeast Asia’s Covid-19 vaccine hub.
State company PT Bio Farma will start producing mRNA doses, according to a statement from the State-Owned Enterprises Ministry, which didn’t name the brand. The company is one of the largest vaccine manufacturers in the region, with the capacity to produce 3.2 billion doses a year.